• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Baxter raises full-year profit forecast on robust demand for medical devices

cafead

Administrator
Staff member
  • cafead   Aug 06, 2024 at 06:02: PM
via Baxter International (BAX.N) on Tuesday raised its annual profit expectations and beat Wall Street estimates for second-quarter profit on strong sales of its medical devices, driven by robust demand for medical care among patients.

article source